Plant-based Vaccines Market, By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Others), By Source (Tobacco Plant, Maize, Potato, Others), By Application (Influenza, Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Others), By Geog

Plant-based Vaccines Market, By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Others), By Source (Tobacco Plant, Maize, Potato, Others), By Application (Influenza, Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Plant-based Vaccines Market, By Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Others), By Source (Tobacco Plant, Maize, Potato, Others), By Application (Influenza, Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Vaccines are the most cost-effective and efficacious means of reducing the disease burden of infectious diseases. Novel approaches to improve product quality and improve access while lowering production costs are continuously sought. Traditionally, vaccines are prepared by using an attenuated version of the pathogen or by preparing and inactivating a disease-causing organism or a suitable part of it, e.g. a toxin, and administering it in quantities sufficient to induce immunity. Such vaccines have the unavoidable potential for contamination with adventitious agents that can infect such materials. A new and exciting possibility is the production of vaccine antigens in genetically modified plants, which can then be extracted and purified by conventional methods. Such vaccines could either be eaten or applied to mucosal surfaces. Plant-derived vaccines have several advantages. They are easily tolerated by patients, can be made cheaply in very large quantities, and the antigens obtained from them are stable and can be kept in storage for a very long time. The likelihood that contamination by a plant virus would have an adverse effect on humans is almost negligible. There are several technical challenges concerning plant-derived vaccines that must be resolved before they can enter wide-scale use, and the regulatory requirements for this novel class of vaccines must be established. In addition, public acceptance of the new technology must be ensured.

Market Dynamics

Increasing product launches by key players in the market are expected to drive the growth of the global plant-based vaccines market over the forecast period. For instance, in December 2022, Evonik, a chemical company, announced the launch of plant-based squalene to boost vaccine efficacy. PhytoSquene is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene.

Key features of the study:

• This report provides an in-depth analysis of the global plant-based vaccines market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global plant-based vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• The key companies covered as a part of this study include Medicago, Inc., IBIO, Inc., Icon Genetics GmbH, Lumen Bioscience, Inc., British American Tobacco Plc., Creative Biolabs, Inc., Leaf Expression Systems Ltd., ZYUS Life Sciences Inc., PlantForm Corporation, and Infectious Disease Research Institute (IDRI).
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global plant-based vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global plant-based vaccines market

Global Plant-based Vaccines Market Detailed Segmentation:

• By Vaccine Type:
• Bacterial Vaccines
• Viral Vaccines
• Parasite Vaccines
• Others
• By Source:
• Tobacco Plant
• Maize
• Potato
• Others
• By Application:
• Influenza
• Covid-19
• Zika Virus
• Ebola Virus
• Poultry Disease
• Others
• By Region:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
• Company Profiles
• Medicago, Inc.
• IBIO, Inc.
• Icon Genetics GmbH
• Lumen Bioscience, Inc.
• British American Tobacco Plc.
• Creative Biolabs, Inc.
• Leaf Expression Systems Ltd.
• ZYUS Life Sciences Inc.
• PlantForm Corporation
• Infectious Disease Research Institute (IDRI)